A Win For Kazia Therapeutics Limited
Tue, Nov 25, 2025 at 07:33 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) rocketted at $12.79, representing a gain of 51.4%. On Tue, Nov 25, 2025, KZIA:NASDAQ hit a New 2-Week High of $12.79. The stock appeared on our News Catalysts scanner on Tue, Nov 18, 2025 at 06:08 PM in the 'BIOTECH' category. From Tue, Nov 11, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 51.36%
- Kohl's Corporation (KSS:NYSE), 42.53%
- Paranovus Entertainment Technology Ltd. (PAVS:NASDAQ), 41.34%
- Symbotic Inc. (SYM:NASDAQ), 39.36%
- Abercrombie & Fitch Co. (ANF:NYSE), 37.54%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 37.45%
- Barnes & Noble Education, Inc. (BNED:NYSE), 36.32%
- Toppoint Holdings Inc. (TOPP:NYSEMKT), 30.84%
- Quantum BioPharma Ltd. (QNTM:NASDAQ), 29.68%